Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137Shilin Yang, Karl Erik Hellström, Ze’ev A. Ronai et al.|Proceedings of the National Academy of Sciences|2004Cited by 44
Human and Mouse CD137 Have Predominantly Different Binding CRDs to Their Respective LigandsLing Yi, Hongtao Zhang, Yanlin Zhao et al.|PLoS ONE|2014Cited by 15
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv–expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusionHongtao Zhang, Ingegerd Hellström, Mary L. Disis et al.|Molecular Cancer Therapeutics|2006Cited by 15